CDKL5 and Lennox-Gastaut syndrome: Stiripentol may be beneficial for GTCS in LGS, while ganaxolone has shown proof-of-concept efficacy in LGS-like phenotypes, particularly in certain genetic epilepsies such as CDKL5 deficiency disorder.